MANNKIND CORP·4

Feb 27, 6:37 PM ET

Kendall David M 4

4 · MANNKIND CORP · Filed Feb 27, 2018

Insider Transaction Report

Form 4
Period: 2018-02-21
Kendall David M
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-02-21$2.76/sh+180,100$497,076180,100 total
    Exercise: $2.76From: 2019-02-12Exp: 2029-02-12Stock Options (180,100 underlying)
Footnotes (1)
  • [F1]25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION